Marrone Bio Innovations, Inc. Reports 2016 First Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- US consumer sentiment near record low as frustration over economy mounts
- Houthi attack on Saudi airport kills 12, over 300 wounded, authorities say
- 8.0 Mag. Earthquake 14 Km Sw Of Pitaloza Arriba Panama - USGS
- Strong Panama quake shakes nation, but avoids major destruction
- Nio stock jumps after Goldman Sachs upgrade to buy
Piper Jaffray Cuts Price Target on Marine Bio (MBII) Following 1Q Report
May 13, 2016 7:58 AM EDTPiper Jaffray maintained an Overweight rating on Marrone Bio Innovations (NASDAQ: MBII), and cut the price target to $1.00 (from $2.00), following the company's 1Q earnings report. Marrone again beat Piper's top line expectations in the March ending quarter as sales growth in the specialty crop market continues to be stronger than expected, more than... More
Marine Bio (MBII) Misses Q1 EPS by 11c
May 12, 2016 4:57 PM EDTMarine Bio (NASDAQ: MBII) reported Q1 EPS of ($0.38), $0.11 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $2.7 million versus the consensus estimate of $3.05 million.
For earnings history and earnings-related data on Marine Bio (MBII) click here.
... More


